id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2003-N-0313-0002,FDA,FDA-2003-N-0313,Toll-Free Number for Reporting Adverse Events on Labeling for Human Drug Products; Correction,Notice,Correction,2004-06-09T04:00:00Z,2004,6,2004-06-04T04:00:00Z,,2016-02-09T17:41:55Z,,0,0,0900006480494efa
FDA-2003-N-0313-0001,FDA,FDA-2003-N-0313,Toll-Free Number for Reporting Adverse Events on Labeling for Human Drug Products; Proposed Rule,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2004-04-23T04:00:00Z,2004,4,2004-04-21T04:00:00Z,2004-07-22T03:59:59Z,2016-02-09T22:01:05Z,,0,0,0900006480494e6b